Protein chip array profiling analysis of sera from neuroblastoma patients

Cancer Letters

Volumn 228, Issue 1-2, 2005, Pages 91-96

  Combaret, Valérie ^a   Bergeron, Christophe ^a   Bréjon, Stéphanie ^a   Iacono, Isabelle ^a   Perol, David ^a   Négrier, Sylvie ^a   Puisieux, Alain ^a  

^a NONE

Author keywords

Neuroblastoma; ProteinChip arrays; SAA; SELDI TOF MS; Serum

Indexed keywords

BIOLOGICAL MARKER; PEPTIDE; SERUM AMYLOID A;

BLOOD ANALYSIS; CANCER GENETICS; CANCER PATIENT; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE MAPPING; GENETIC ANALYSIS; HUMAN; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN MICROARRAY; SERUM; SHORT SURVEY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TECHNOLOGY;

EID: 23944523790     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.12.053     Document Type: Review

References (16)

1. E.F. Petricoin, A.M. Ardekani, B.A. Hitt, P.J. Levine, V.A. Fusaro, and S.M. Steinberg Use of proteomic patterns in serum to identify ovarian cancer Lancet 359 2002 572 577
2. B.L. Adam, Y. Qu, J.W. Davis, M.D. Ward, M.A. Clements, and L.H. Cazares Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men Cancer Res. 62 2002 3609 3614
3. E.F. Petricoin, D.K. Ornstein, C.P. Paweletz, A. Ardekani, P.S. Hackett, and B.A. Hitt Serum proteomic patterns for detection of prostate cancer J. Natl Cancer Inst. 94 2002 1576 1578
4. J. Li, Z. Zhang, J. Rosenzweig, Y.Y. Wang, and D.W. Chan Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer Clin. Chem. 48 2002 1296 1304
5. P. Thiesse, M.A. Hany, V. Combaret, D. Ranchère-Vince, E. Bouffet, and C. Bergeron Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma Eur. J. Cancer 36 2000 1544 1551
6. J.J. Shuster, N.B. McWilliams, R. Castleberry, R. Nitschke, E.I. Smith, and G. Altshuler Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning study Am. J. Clin. Oncol. 15 1992 295 303
7. P.M. Zeltzer, P.J. Marangos, A.E. Evans, and S.L. Schneider Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course Cancer 57 1986 1230 1234
8. H.W. Hann, A.E. Evans, S.E. Siegel, K.Y. Wong, H. Sather, and A. Dalton Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Children Cancer Study Group experience Cancer Res. 45 1985 2843 2848
9. W.C. Cho, T.T. Yip, C. Yip, V. Yip, V. Thulasiraman, and R.K. Ngan Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling Clin. Cancer Res. 10 2004 43 52
10. M. Kimura, Y. Tomita, T. Imai, T. Saito, A. Katagiri, and Y. Ohara-Mikami Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma Cancer 92 2001 2072 2075
11. B.A. Howard, M.Z. Wang, M.J. Campa, C. Corro, M.C. Fitzgerald, and E.F. Patz Jr Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis Proteomics 3 2003 1720 1724
12. I. Glojnaric, M.T. Casl, D. Simic, and J. Lukac Serum amyloid A protein (SAA) in colorectal carcinoma Clin. Chem. Lab. Med. 39 2001 129 133
13. J. Tolson, R. Bogumil, E. Brunst, H. Beck, R. Elsner, and A. Humeny Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients Lab. Invest. 84 2004 845 856
14. G. Husby, G. Marhaug, B. Dowton, K. Sletten, and J.D. Sipe Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis, amyloid, Int J. Exp. Clin. Invest. 1 1994 119 137
15. M. Merchant, and S.R. Weinberger Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry Electrophoresis 21 2000 1164 1177
16. E.P. Diamandis Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations Mol. Cell Proteomics 3 2004 367 378